At JP Morgan, Investors Focus on M&A; Thermo Hints at LC Market as ABI Eyes Cell Analysis | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
SAN FRANCISCO — Investors attending the JP Morgan Healthcare Conference here this week appear to be most interested in the M&A strategies of the molecular biology tools firms presenting at the conference. And based on comments made by executives, it looks like 2007 will be another busy year for mergers and acquisitions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.